Naltrexone, a non-specific opioid receptor antagonist, has been shown to support all of the following, except:
a) Increase the percentage of ETOH-abstinent days
b) Reduce the total number of drinks per day
c) Decrease ETOH cravings
d) Produce a negatively-reinforcing effect if used with ETOH